Barclays Sees 32% Upside In Alkermes Shares, Says 2016 Vivitrol Sales 'Could Easily Top Guidance'
July 12, 2016 at 11:28 AM EDT
Barclays sees a potential upside of 32 percent in Alkermes Plc (NASDAQ: ALKS) shares, and subsequently raised the price target on the ...